文献速递妇科

醋酸乌利司他降低子宫肌瘤患者血清与肿瘤组织中转化生长因子β3浓度

Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids.
PubMed 文献 · Fertil Steril · 2018-03-07

该回顾性队列研究纳入141例患者,比较未激素治疗的子宫肌瘤患者、醋酸乌利司他治疗3个月的子宫肌瘤患者及对照组的血清和肌瘤组织TGF-β3浓度。UPA组血清与组织TGF-β3均值均显著低于未治疗组,TGF-β3浓度与年龄、BMI无显著相关性。作者认为TGF-β3降低可能是UPA作用于肌瘤生物学的重要环节,需进一步研究。

要点

  • UPA组血清TGF-β3均值10.88±7.15 pg/mL,低于未治疗组32.24±34.55 pg/mL。
  • UPA组组织TGF-β3均值99.99±60.63 pg/mg,低于未治疗组171.29±91.81 pg/mg。
  • TGF-β3浓度与年龄、BMI均无统计学显著相关性。

核心结论

  • 子宫肌瘤患者血清和组织TGF-β3浓度降低可能是UPA影响肌瘤生物学的重要环节。
  • 作者认为该领域需进一步研究。

研究设计与样本

  • 回顾性队列研究,在大学教学医院开展,共纳入141例患者,分为子宫肌瘤未用UPA组、子宫肌瘤UPA组和对照组。
  • 干预包括病史与查体、生殖道超声、血液与组织取样,以及血清和组织TGF-β3浓度测定。
  • 主要结局指标为UPA治疗3个月、年龄和BMI对血清及肌瘤组织TGF-β3水平的影响。

主要发现

  • 血清TGF-β3均值:未用UPA组32.24±34.55 pg/mL,UPA组10.88±7.15 pg/mL,对照组11.97±10.30 pg/mL。
  • 组织TGF-β3均值:未用UPA组171.29±91.81 pg/mg,UPA组99.99±60.63 pg/mg。
  • UPA治疗患者的血清和组织TGF-β3均值统计学显著低于未用UPA组。
  • TGF-β3浓度与年龄或BMI之间未发现统计学显著相关性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate and compare transforming growth factor β3 (TGF-β3) serum concentration in patients with uterine fibroids (UFs) without hormone treatment, treated with ulipristal acetate (UPA), and controls; to evaluate TGF-β3 concentrations in UF tissue in patients without hormone treatment and those treated with UPA; and to evaluate the correlations of age and body mass index (BMI) with TGF-β3 serum and UF tissue levels between the groups. DESIGN: Retrospective cohort study. SETTING: University teaching hospital. PATIENT(S): A total of 141 patients divided into three groups: UFs non-UPA, UFs, and UPA, controls. INTERVENTION(S): Medical history and examination, genital ultrasound scan, blood and tissue sampling, and measurement of TGF-β3 serum and tissue concentrations. MAIN OUTCOME MEASURE(S): Evaluation of the impact of UPA (3 months treatment), age and BMI on TGF-β3 serum and UF tissue levels. RESULT(S): The values of TGF-β3 serum and tissue concentrations statistically significantly differed between the non-UPA and UPA groups. The mean TGF-β3 serum concentrations were non-UPA group 32.24 ± 34.55 pg/mL, UPA group 10.88 ± 7.15 pg/mL, and controls 11.97 ± 10.30 pg/mL. The mean TGF-β3 tissue concentrations were non-UPA group 171.29 ± 91.81 pg/mg and UPA group 99.99 ± 60.63 pg/mg. Statistically significantly lower mean TGF-β3 serum and tissue concentrations were observed in patients treated with UPA. No statistically significant correlations between TGF-β3 concentrations and age or BMI were found. CONCLUSION(S): Reduction of serum and tissue TGF-β3 concentrations in UFs may be an important component of the effect of UPA on UF biology. Further research in this area is necessary.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Ciebiera M, Włodarczyk M, Wrzosek M, et al. Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids. Fertil Steril. 2018. PMID: 29525690. doi:10.1016/j.fertnstert.2017.11.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。